Medpace Holdings revenue and financials

MEDP · NASDAQ · USD

$602.90Change from previous close: −2.84%Absolute change: −$17.61

Close · October 6, 2026

In the fiscal year ended December 2025, Medpace Holdings reported revenue of $2.53B (+19.97% year over year). Net income was $451.12M, a net margin of 17.8%.

Annual revenue · 2025: $2.53B
  1. $421.58M2016
  2. $436.15M2017
  3. $704.59M2018
  4. $860.97M2019
  5. $925.93M2020
  6. $1.14B2021
  7. $1.46B2022
  8. $1.89B2023
  9. $2.11B2024
  10. $2.53B2025

Fiscal year ending in December. Sources and method on the page Methodology and sources.

At a glance

Revenue growth
+19.97%
2025 vs 2024
Net income growth
+11.56%
2025 vs 2024
Net margin
17.8%
2024: 19.2%

Financial data

Amounts in millions of USD; per-share values in USD; shares in millions.

Balance sheet · Quarterly
ItemQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
Total assets2,0572,1301,9751,7531,5721,8972,1012,0841,9201,7961,6571,487
Current assets1,0501,1399907375218211,0291,033873745594449
Cash and equivalents50365349728546.344166965751140724595.2
Receivables442395427373378298321311301279308293
Net property, plant and equipment283263249257265258252255256257265259
Goodwill662662662662662662662662662662662662
Other intangible assets33.133.333.433.733.934.134.434.735.135.435.836.4
Current liabilities1,4351,3451,3441,2841,2201,1221,1051,041993957925849
Accounts payable37.534.428.126.543.361.332.526.227.424.431.929.0
Total debt120122114119125———————
Total liabilities1,6231,5311,5161,4591,3991,3041,2751,2031,1561,1241,0981,016
Total equity (incl. minority)434598459294172594826881764672559471
Retained earnings-511-336-460-596-703-2708.265.6-30.8-119-222-300